Altered serotonin receptor subtypes mediate coronary microvascular hyperreactivity in pigs with chronic inhibition of nitric oxide synthesis

Circulation

Volumn 94, Issue 2, 1996, Pages 182-189

  Kadokami, Toshiaki ^b   Egashira, Kensuke ^a   Kuwata, Kouichi ^b   Fukumoto, Yoshihiro ^b   Kozai, Toshiyuki ^b   Yasutake, Hiroshi ^b   Kuga, Takeshi ^b   Shimokawa, Hiroaki ^b   Sueishi, Katsuo ^a   Takeshita, Akira ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

circulation; endothelium derived factors; microcirculation; serotonin

Indexed keywords

KETANSERIN; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 2 ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME INHIBITION; HISTOPATHOLOGY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 8944237009     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.2.182     Document Type: Article

References (34)

1. Bassenge E, Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis. 1988;30:349-380.
2. Lüscher TF, Noll G. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol. 1994;24(suppl 3):S16-S26.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
4. Meyers PR, Minor RL Jr, Guerra R Jr, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrocysteine than nitric oxide. Nature. 1990;345:161-163.
5. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431-1438.
6. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
7. Minor RL, Myers PR, Guerra R Jr, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109-2116.
8. Zeiher AM, Drexler H, Wollschager H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans; importance of the functional integrity of the endotheliurn. J Am Coll Cardiol 1989;14:1181-1190.
9. Gordon JB, Ganz P, Nabel EG, Zebede J, Mudge GH, Alexander RW, Selwyn AP. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest. 1989;83:1946-1952.
10. Chilian WM, Dellsperger KC, Layne SM, Eastham CL, Armstrong MA, Marcus ML, Heistad DD. Effects of atherosclerosis on the coronary microcirculation. Am J Physiol. 1990;258(Heart Circ Physiol 27):H529-H539.
11. Kuo L, Davis MJ, Cannon MS, Chillian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation: restoration of endothelium-dependent responses by L-arginine. Circ Res. 1992;70:465-476.
12. Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 1993;91:29-37.
13. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659-1664.
14. Quyyumi AA, Canon RO III, Panza JA, Diodati JG, Epstein SE. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation. 1992;86:1864-1871.
15. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation. 1995;91:2345-2352.
16. Ito A, Egashira K, Kadokami T, Fukumoto Y, Takayanagi T, Shimokawa H, Takeshita A. Chronic inhibition of endothelium-derived nitric oxide causes structural and functional abnormalities in coronary microvessels but not in large epicardial vessels in pigs. Circulation. 1995;92:2636-2644.
17. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary micro vascular remodeling in rats. Hypertension. 1995;26: 957-962.
18. Chester AH, Martin GR, Bodelsson M, Arneklo-Nobin B, Tadjkarimi S, Tornebrandt K, Yacoub MH. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res. 1990;24:932-937.
19. 2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation. 1993;87:874-880.
20. 2+ mobilization causes supersensitivity of contractile response to serotonin in atherosclerotic arteries. Circ Res. 1994;75:1096-1102.
21. McFadden EP, Clarke JG, Davis GJ, Kaski JC, Haider AW, Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med. 1991;324:648-654.
22. MacFadden EP, Bauters C, Lablanche JM, Leroy F, Clarke JG, Henry M, Schandrin C, Davis GJ, Maseri A, Bertrand ME. Effect of ketanserin on proximal and distal coronary constrictor responses to intracoronary infusion of serotonin in patients with stable angina, patients with variant angina, and control patients. Circulation. 1992;86:187-195.
23. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80: 198-205.
24. Peroutka SJ. 5-Hydroxytryptamine receptor subtypes. Pharmacol Toxicol. 1990;67:373-383.
25. Fukai T, Egashira K, Hata H, Numaguchi K, Ohara Y, Takahashi T, Tomoike H, Takeshita A. Serotonin-induced coronary spasm in a swine model: a minor role of defective endothelium-derived relaxing factor. Circulation. 1993;88:1922-1930.
26. Egashira K, Tomoike H, Yamamoto Y, Yamada A, Hayashi Y, Nakamura M. Histamine-induced coronary spasm in regions of intimal thickening in miniature pigs: roles of serum cholesterol and spontaneous or induced intimai thickening. Circulation. 1986;74:826-837.
27. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
28. Arnal JF, Warin L, Michel JB. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest. 1992;90:647-652.
29. Richard V, Tanner FC, Tschudi M, Luscher TF. Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol. 1990;259:H1433-H1439.
30. Tschudi M, Richard V, Bühler FR, Lüscher TF. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol. 1991;260:H13-H20.
31. Connor HE, Feniuk W, Humphrey PPA. 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol. 1989;161:91-94.
32. Toda N, Okamura T. Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries. J Pharmacol Exp Ther. 1990;253:676-682.
33. IDβ receptors. Circulation. 1994;90: 1141-1153.
34. Golino P, Piscione F, Willerson JT, Cappeli-Bigazzi M, Focaccio A, Villari B, Indolfi C, Russolillo E, Condorelli M, Chiariello M. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med. 1991;324:641-648.